コロラド州における非ホジキンリンパ腫の臨床試験
コロラド州内の拠点で、非ホジキンリンパ腫に関する20件の研究が参加者を募集しています。
コロラド州内の都市
公式研究テキスト（英語）
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
- Children's Hospital Colorado, Aurora
被験者募集中観察研究
0歳〜38歳 · 全性別 · 2026/10/01更新 · NCT06131801A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Uchealth North, Fort Collins
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/28更新 · NCT05006716A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
- Colorado Blood Cancer Institute ( Site 7000), Denver
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT07519772Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
- Colorado Blood Cancer Institute ( Site 2726), Denver
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/24更新 · NCT04728893A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- Colorado Blood Cancer Institute, Denver
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07226843A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
- University of Colorado Denver - School of Medicine - Anschutz Medical Campus, Aurora
- Colorado Blood Cancer Institute, Denver
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/22更新 · NCT07101328Safety and Preliminary Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma
- University of Colorado, Aurora
- Colorado Blood Cancer Institute (Sarah Cannon), Denver
被験者募集中第1相
18歳〜100歳 · 全性別 · 2026/09/15更新 · NCT05798897Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
- Rocky Mountain Cancer Centers, LLP, Aurora
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/11更新 · NCT06806033Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
- Colorado Blood Cancer Institute, Denver
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/08/25更新 · NCT05826535Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital Colorado, Aurora
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- Colorado Blood Cancer Institute, Denver
被験者募集中第1/2相
13歳〜90歳 · 全性別 · 2026/08/06更新 · NCT06533579A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- University of Colorado, Aurora
- Colorado Blood Cancer Institute, Denver
被験者募集中第3相
18歳以上 · 全性別 · 2026/08/04更新 · NCT07188558DALY II USA/ MB-CART2019.1 for DLBCL
- Colorado Blood Cancer Institute, Denver
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/13更新 · NCT04792489Preliminary Safety and Tolerability of CD19x22 CAR T Cells in Adolescent and Adult R/R B-NHL Patients
- University of Colorado Hospital, Aurora
被験者募集中第1相
16歳以上 · 全性別 · 2026/07/09更新 · NCT05098613A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
- Children's Hospital Colorado, Aurora
- University of Colorado Hospital, Aurora
- Presbyterian St. Luke's/Colorado Blood Cancer Institute, Denver
被験者募集中観察研究
全年齢 · 全性別 · 2026/07/06更新 · NCT01351545SynKIR-310 for Relapsed/Refractory B-NHL
- Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute, Denver
被験者募集中第1相
18歳以上 · 全性別 · 2026/04/14更新 · NCT06544265Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
- Rocky Mountain Cancer Centers-Aurora, Aurora
- Rocky Mountain Cancer Centers-Boulder, Boulder
- Rocky Mountain Cancer Centers - Centennial, Centennial
- 他12件
被験者募集中観察研究
18歳以上 · 全性別 · 2026/03/17更新 · NCT06418204Improving Communication and Building a Stronger Medical Home Among Spanish-speaking Families
- Children's Hospital Colorado, Aurora
被験者募集中観察研究
22歳以下 · 全性別 · 2026/02/05更新 · NCT05425992SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Aurora
- Massive Bio SYNERGY-AI site, Denver
- Massive Bio SYNERGY-AI site, Littleton
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
- Colorado Blood Cancer Institute, Denver
被験者募集中第1相
18歳以上 · 全性別 · 2025/10/02更新 · NCT05780034ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。